{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:56:01Z","timestamp":1793094961530,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00134-024-07341-7","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T06:01:58Z","timestamp":1711000918000},"page":"502-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":218,"title":["Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-9740","authenticated-orcid":false,"given":"Matteo","family":"Bassetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele R.","family":"Giacobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Agvald-Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alastruey-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan W.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco G.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"De Waele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Garnacho-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souha S.","family":"Kanj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Lamoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garyphallia","family":"Poulakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Sanguinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio S.","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Asperges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cortegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Grecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Karaiskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Le Bihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus L.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Peghin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rebuffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Zuccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Scudeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Study Group for Infections in Critically Ill Patients of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG), the European Society of Intensive Care Medicine (ESICM), the European Confederation of Medical Mycology (ECMM), the Mycoses Study Group Education and Research Consortium (MSGERC), the International Society of Antimicrobial Chemotherapy (ISAC), the Interna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Coombs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"supp_l 1","key":"7341_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jac\/dkx032","volume":"72","author":"M Bassetti","year":"2017","unstructured":"Bassetti M, Bouza E (2017) Invasive mould infections in the ICU setting: complexities and solutions. J Antimicrob Chemother 72(supp_l 1):39\u201347. https:\/\/doi.org\/10.1093\/jac\/dkx032","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"7341_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","volume":"23","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Giacobbe DR, Vena A et al (2019) Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care 23(1):219. https:\/\/doi.org\/10.1186\/s13054-019-2497-3","journal-title":"Crit Care"},{"issue":"1","key":"7341_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/viru.26187","volume":"5","author":"J Delaloye","year":"2014","unstructured":"Delaloye J, Calandra T (2014) Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5(1):161\u2013169. https:\/\/doi.org\/10.4161\/viru.26187","journal-title":"Virulence"},{"issue":"3","key":"7341_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.idc.2017.05.005","volume":"31","author":"L Ostrosky-Zeichner","year":"2017","unstructured":"Ostrosky-Zeichner L, Al-Obaidi M (2017) Invasive fungal infections in the intensive care unit. Infect Dis Clin N Am 31(3):475\u2013487. https:\/\/doi.org\/10.1016\/j.idc.2017.05.005","journal-title":"Infect Dis Clin N Am"},{"key":"7341_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","volume":"19","author":"FS Taccone","year":"2015","unstructured":"Taccone FS, Van den Abeele AM, Bulpa P et al (2015) Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 19:7. https:\/\/doi.org\/10.1186\/s13054-014-0722-7","journal-title":"Crit Care"},{"issue":"9","key":"7341_CR6","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","volume":"41","author":"M Bassetti","year":"2015","unstructured":"Bassetti M, Righi E, Ansaldi F et al (2015) A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 41(9):1601\u20131610. https:\/\/doi.org\/10.1007\/s00134-015-3866-2","journal-title":"Intensive Care Med"},{"key":"7341_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myab064","author":"S Kluge","year":"2021","unstructured":"Kluge S, Strauss R, Kochanek M, Weigand MA, Rohde H, Lahmer T (2021) Aspergillosis: emerging risk groups in critically ill patients. Med Mycol. https:\/\/doi.org\/10.1093\/mmy\/myab064","journal-title":"Med Mycol"},{"issue":"5","key":"7341_CR8","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","volume":"37","author":"O Leroy","year":"2009","unstructured":"Leroy O, Gangneux JP, Montravers P et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005\u20132006). Crit Care Med 37(5):1612\u20131618. https:\/\/doi.org\/10.1097\/CCM.0b013e31819efac0","journal-title":"Crit Care Med"},{"issue":"4","key":"7341_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","volume":"28","author":"J Prattes","year":"2022","unstructured":"Prattes J, Wauters J, Giacobbe DR et al (2022) Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 28(4):580\u2013587. https:\/\/doi.org\/10.1016\/j.cmi.2021.08.014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"7341_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3201\/eid2704.204895","volume":"27","author":"J Salmanton-Garcia","year":"2021","unstructured":"Salmanton-Garcia J, Sprute R, Stemler J et al (2021) COVID-19-associated pulmonary aspergillosis, March\u2013August 2020. Emerg Infect Dis 27(4):1077\u20131086. https:\/\/doi.org\/10.3201\/eid2704.204895","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"7341_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"A Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe A, Rijnders BJA, Philips N et al (2018) Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 6(10):782\u2013792. https:\/\/doi.org\/10.1016\/S2213-2600(18)30274-1","journal-title":"Lancet Respir Med"},{"issue":"11","key":"7341_CR12","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3201\/eid2711.211174","volume":"27","author":"NAF Janssen","year":"2021","unstructured":"Janssen NAF, Nyga R, Vanderbeke L et al (2021) Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis (1). Emerg Infect Dis 27(11):2892\u20132898. https:\/\/doi.org\/10.3201\/eid2711.211174","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"7341_CR13","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","volume":"39","author":"M Bassetti","year":"2013","unstructured":"Bassetti M, Marchetti M, Chakrabarti A et al (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39(12):2092\u20132106. https:\/\/doi.org\/10.1007\/s00134-013-3109-3","journal-title":"Intensive Care Med"},{"issue":"1","key":"7341_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, Van den Abeele AM et al (2012) A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 186(1):56\u201364. https:\/\/doi.org\/10.1164\/rccm.201111-1978OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"7341_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"Bulpa P, Dive A, Sibille Y (2007) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30(4):782\u2013800. https:\/\/doi.org\/10.1183\/09031936.00062206","journal-title":"Eur Respir J"},{"issue":"6","key":"7341_CR16","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A et al (2021) Defining and managing COVID-19-associated pulmonary Aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 21(6):e149\u2013e162. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"7341_CR17","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc4823","volume":"10","author":"KH Vandewoude","year":"2006","unstructured":"Vandewoude KH, Blot SI, Depuydt P et al (2006) Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10(1):R31. https:\/\/doi.org\/10.1186\/cc4823","journal-title":"Crit Care"},{"issue":"8","key":"7341_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","volume":"47","author":"PE Verweij","year":"2021","unstructured":"Verweij PE, Bruggemann RJM, Azoulay E et al (2021) Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med 47(8):819\u2013834. https:\/\/doi.org\/10.1007\/s00134-021-06449-4","journal-title":"Intensive Care Med"},{"issue":"8","key":"7341_CR19","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","volume":"46","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Rijnders BJA, Bruggemann RJM et al (2020) Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med 46(8):1524\u20131535. https:\/\/doi.org\/10.1007\/s00134-020-06091-6","journal-title":"Intensive Care Med"},{"issue":"6","key":"7341_CR20","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 71(6):1367\u20131376. https:\/\/doi.org\/10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"7341_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/myc.12869","volume":"62","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Scudeller L, Giacobbe DR et al (2019) Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses 62(4):310\u2013319. https:\/\/doi.org\/10.1111\/myc.12869","journal-title":"Mycoses"},{"issue":"1","key":"7341_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jinf.2020.03.065","volume":"81","author":"M Bassetti","year":"2020","unstructured":"Bassetti M, Giacobbe DR, Grecchi C et al (2020) Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis. J Infect 81(1):131\u2013146. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.065","journal-title":"J Infect"},{"issue":"3","key":"7341_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/jof7030176","volume":"7","author":"DR Giacobbe","year":"2021","unstructured":"Giacobbe DR, Cortegiani A, Karaiskos I et al (2021) Performance of existing definitions and tests for the diagnosis of invasive fungal diseases other than invasive candidiasis and invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis. J Fungi (Basel, Switzerland) 7(3):176. https:\/\/doi.org\/10.3390\/jof7030176","journal-title":"J Fungi (Basel, Switzerland)"},{"issue":"12","key":"7341_CR24","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/myc.13515","volume":"65","author":"DR Giacobbe","year":"2022","unstructured":"Giacobbe DR, Asperges E, Cortegiani A et al (2022) Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: a systematic review with qualitative evidence synthesis. Mycoses 65(12):1073\u20131111. https:\/\/doi.org\/10.1111\/myc.13515","journal-title":"Mycoses"},{"issue":"5","key":"7341_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jinf.2022.08.003","volume":"85","author":"M Bassetti","year":"2022","unstructured":"Bassetti M, Zuccaro V, Asperges E, Scudeller L, Giacobbe DR, Investigators F (2022) Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: an update including COVID-19 data. J Infect 85(5):573\u2013607. https:\/\/doi.org\/10.1016\/j.jinf.2022.08.003","journal-title":"J Infect"},{"issue":"1","key":"7341_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1017\/s0266462300002774","volume":"2","author":"RH Brook","year":"1986","unstructured":"Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE (1986) A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 2(1):53\u201363. https:\/\/doi.org\/10.1017\/s0266462300002774","journal-title":"Int J Technol Assess Health Care"},{"issue":"2","key":"7341_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"7341_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1745-6215-13-132","volume":"13","author":"PR Williamson","year":"2012","unstructured":"Williamson PR, Altman DG, Blazeby JM et al (2012) Developing core outcome sets for clinical trials: issues to consider. Trials 13:132. https:\/\/doi.org\/10.1186\/1745-6215-13-132","journal-title":"Trials"},{"issue":"1","key":"7341_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jinf.2017.03.011","volume":"75","author":"O Baldesi","year":"2017","unstructured":"Baldesi O, Bailly S, Ruckly S et al (2017) ICU-acquired candidaemia in France: epidemiology and temporal trends, 2004\u20132013\u2014a study from the REA-RAISIN network. J Infect 75(1):59\u201367. https:\/\/doi.org\/10.1016\/j.jinf.2017.03.011","journal-title":"J Infect"},{"issue":"6","key":"7341_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","volume":"40","author":"M Bassetti","year":"2014","unstructured":"Bassetti M, Righi E, Ansaldi F et al (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40(6):839\u2013845. https:\/\/doi.org\/10.1007\/s00134-014-3310-z","journal-title":"Intensive Care Med"},{"issue":"2","key":"7341_CR31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s40121-021-00585-6","volume":"11","author":"M Bassetti","year":"2022","unstructured":"Bassetti M, Vena A, Giacobbe DR et al (2022) Risk factors for intra-abdominal candidiasis in intensive care units: results from EUCANDICU study. Infect Dis Ther 11(2):827\u2013840. https:\/\/doi.org\/10.1007\/s40121-021-00585-6","journal-title":"Infect Dis Ther"},{"issue":"1","key":"7341_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13054-020-2793-y","volume":"24","author":"M Bassetti","year":"2020","unstructured":"Bassetti M, Vena A, Meroi M et al (2020) Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts. Crit Care 24(1):117. https:\/\/doi.org\/10.1186\/s13054-020-2793-y","journal-title":"Crit Care"},{"issue":"4","key":"7341_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","volume":"39","author":"DH Kett","year":"2011","unstructured":"Kett DH, Azoulay E, Echeverria PM, Vincent JL, Extended Prevalence of Infection in ICUSGoI (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39(4):665\u2013670. https:\/\/doi.org\/10.1097\/CCM.0b013e318206c1ca","journal-title":"Crit Care Med"},{"key":"7341_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13054-016-1229-1","volume":"20","author":"JA Paiva","year":"2016","unstructured":"Paiva JA, Pereira JM, Tabah A et al (2016) Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study. Crit Care 20:53. https:\/\/doi.org\/10.1186\/s13054-016-1229-1","journal-title":"Crit Care"},{"issue":"1","key":"7341_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","volume":"55","author":"AM Tortorano","year":"2012","unstructured":"Tortorano AM, Dho G, Prigitano A et al (2012) Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006\u20132008). Mycoses 55(1):73\u201379. https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02044.x","journal-title":"Mycoses"},{"issue":"21","key":"7341_CR36","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302(21):2323\u20132329. https:\/\/doi.org\/10.1001\/jama.2009.1754","journal-title":"JAMA"},{"issue":"Suppl 2","key":"7341_CR37","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","volume":"72","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Azoulay E, Kullberg BJ et al (2021) EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group. Clin Infect Dis 72(Suppl 2):S121\u2013S127. https:\/\/doi.org\/10.1093\/cid\/ciaa1751","journal-title":"Clin Infect Dis"},{"key":"7341_CR38","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","volume":"4","author":"PG Pappas","year":"2018","unstructured":"Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ (2018) Invasive candidiasis. Nat Rev Dis Primers 4:18026. https:\/\/doi.org\/10.1038\/nrdp.2018.26","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"7341_CR39","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/cid\/cit006","volume":"56","author":"CJ Clancy","year":"2013","unstructured":"Clancy CJ, Nguyen MH (2013) Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 56(9):1284\u20131292. https:\/\/doi.org\/10.1093\/cid\/cit006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"7341_CR40","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/annonc\/mdr407","volume":"23","author":"M Ruhnke","year":"2012","unstructured":"Ruhnke M, Bohme A, Buchheidt D et al (2012) Diagnosis of invasive fungal infections in hematology and oncology-guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann Oncol 23(4):823\u2013833. https:\/\/doi.org\/10.1093\/annonc\/mdr407","journal-title":"Ann Oncol"},{"issue":"5","key":"7341_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/antibiotics11050697","volume":"11","author":"JJ De Waele","year":"2022","unstructured":"De Waele JJ, Boelens J, Van De Putte D, Huis In \u2019t Veld D, Coenye T (2022) The role of abdominal drain cultures in managing abdominal infections. Antibiotics (Basel). 11(5):97. https:\/\/doi.org\/10.3390\/antibiotics11050697","journal-title":"Antibiotics (Basel)."},{"issue":"4","key":"7341_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","volume":"30","author":"S Husain","year":"2011","unstructured":"Husain S, Mooney ML, Danziger-Isakov L et al (2011) A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant 30(4):361\u2013374. https:\/\/doi.org\/10.1016\/j.healun.2011.01.701","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"7341_CR43","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2165\/00003495-200767110-00004","volume":"67","author":"G Maschmeyer","year":"2007","unstructured":"Maschmeyer G, Haas A, Cornely OA (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67(11):1567\u20131601. https:\/\/doi.org\/10.2165\/00003495-200767110-00004","journal-title":"Drugs"},{"key":"7341_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2334-13-29","volume":"13","author":"JW Baddley","year":"2013","unstructured":"Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M (2013) Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis 13:29. https:\/\/doi.org\/10.1186\/1471-2334-13-29","journal-title":"BMC Infect Dis"},{"issue":"6","key":"7341_CR45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","volume":"170","author":"W Meersseman","year":"2004","unstructured":"Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E (2004) Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 170(6):621\u2013625. https:\/\/doi.org\/10.1164\/rccm.200401-093OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"7341_CR46","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00134-021-06471-6","volume":"47","author":"J Prattes","year":"2021","unstructured":"Prattes J, Wauters J, Giacobbe DR, Lagrou K, Hoenigl M, Group E-CS (2021) Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med 47(10):1158\u20131160. https:\/\/doi.org\/10.1007\/s00134-021-06471-6","journal-title":"Intensive Care Med"},{"issue":"4","key":"7341_CR47","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","volume":"196","author":"FL van de Veerdonk","year":"2017","unstructured":"van de Veerdonk FL, Kolwijck E, Lestrade PP et al (2017) Influenza-associated aspergillosis in critically ill patients. Am J Respir Crit Care Med 196(4):524\u2013527. https:\/\/doi.org\/10.1164\/rccm.201612-2540LE","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"7341_CR48","doi-asserted-by":"publisher","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","volume":"73","author":"M Bartoletti","year":"2021","unstructured":"Bartoletti M, Pascale R, Cricca M et al (2021) Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study. Clin Infect Dis 73(11):e3606\u2013e3614. https:\/\/doi.org\/10.1093\/cid\/ciaa1065","journal-title":"Clin Infect Dis"},{"key":"7341_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02136-20","author":"AM Borman","year":"2020","unstructured":"Borman AM, Palmer MD, Fraser M et al (2020) COVID-19-associated invasive aspergillosis: data from the UK National Mycology Reference Laboratory. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.02136-20","journal-title":"J Clin Microbiol"},{"issue":"3","key":"7341_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238825","volume":"16","author":"T Lahmer","year":"2021","unstructured":"Lahmer T, Kriescher S, Herner A et al (2021) Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study. PLoS ONE 16(3):e0238825. https:\/\/doi.org\/10.1371\/journal.pone.0238825","journal-title":"PLoS ONE"},{"issue":"5","key":"7341_CR51","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","volume":"202","author":"R Nyga","year":"2020","unstructured":"Nyga R, Maizel J, Nseir S et al (2020) Invasive tracheobronchial aspergillosis in critically ill patients with severe influenza. A clinical trial. Am J Respir Crit Care Med 202(5):708\u2013716. https:\/\/doi.org\/10.1164\/rccm.201910-1931OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"7341_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cid\/ciab223","volume":"74","author":"N Permpalung","year":"2022","unstructured":"Permpalung N, Chiang TP, Massie AB et al (2022) Coronavirus disease 2019-associated pulmonary aspergillosis in mechanically ventilated patients. Clin Infect Dis 74(1):83\u201391. https:\/\/doi.org\/10.1093\/cid\/ciab223","journal-title":"Clin Infect Dis"},{"issue":"5","key":"7341_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/rccm.202005-1883ED","volume":"202","author":"FL van de Veerdonk","year":"2020","unstructured":"van de Veerdonk FL, Wauters J, Verweij PE (2020) Invasive aspergillus tracheobronchitis emerging as a highly lethal complication of severe influenza. Am J Respir Crit Care Med 202(5):646\u2013648. https:\/\/doi.org\/10.1164\/rccm.202005-1883ED","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"7341_CR54","doi-asserted-by":"publisher","first-page":"e0122921","DOI":"10.1128\/JCM.01229-21","volume":"59","author":"M Ergun","year":"2021","unstructured":"Ergun M, Bruggemann RJM, Alanio A et al (2021) Aspergillus test profiles and mortality in critically ill COVID-19 patients. J Clin Microbiol 59(12):e0122921. https:\/\/doi.org\/10.1128\/JCM.01229-21","journal-title":"J Clin Microbiol"},{"issue":"4","key":"7341_CR55","doi-asserted-by":"publisher","first-page":"e0229821","DOI":"10.1128\/jcm.02298-21","volume":"60","author":"DR Giacobbe","year":"2022","unstructured":"Giacobbe DR, Prattes J, Wauters J et al (2022) Prognostic impact of bronchoalveolar lavage fluid galactomannan and aspergillus culture results on survival in COVID-19 intensive care unit patients: a post hoc analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-associated pulmonary aspergillosis study. J Clin Microbiol 60(4):e0229821. https:\/\/doi.org\/10.1128\/jcm.02298-21","journal-title":"J Clin Microbiol"},{"key":"7341_CR56","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3233\/SHTI220521","volume":"294","author":"G Di Meco","year":"2022","unstructured":"Di Meco G, Mora S, Giacobbe DR et al (2022) A wide database for a multicenter study on Pneumocystis jirovecii pneumonia in intensive care units. Stud Health Technol Inform 294:557\u2013558. https:\/\/doi.org\/10.3233\/SHTI220521","journal-title":"Stud Health Technol Inform"},{"issue":"1","key":"7341_CR57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13054-023-04608-1","volume":"27","author":"DR Giacobbe","year":"2023","unstructured":"Giacobbe DR, Dettori S, Di Pilato V et al (2023) Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG. Crit Care 27(1):323. https:\/\/doi.org\/10.1186\/s13054-023-04608-1","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07341-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-024-07341-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07341-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T04:03:25Z","timestamp":1713153805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-024-07341-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7341"],"URL":"https:\/\/doi.org\/10.1007\/s00134-024-07341-7","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Outside the submitted work, MB reports research grants and\/or personal fees for advisor\/consultant and\/or speaker\/chairman from BioM\u00e9rieux, Cidara, Gilead, Menarini, MSD, Pfizer, and Shionogi. Outside the submitted work, DRG reports investigator-initiated grants from Pfizer Inc, Shionogi, BioM\u00e9rieux, and Gilead Italia, and personal fees for advisor\/speaker from Pfizer Inc., Menarini, and Tillotts Pharma. Outside the submitted work, AAI reports fees for educational lectures from Gilead, Pfizer, and MSD; grants from Instituto de Salud Carlos III and ESCMID; advisor for the Joint Program Initiative on Antimicrobial Resistance and the WHO Technical Expert Group for the Development of the Fungal Priority Pathogens List; travel support from Gilead. Outside the submitted work, EA reports grants from Pfizer and MSD, and honoraria for lectures or presentations from Gilead, Pfizer, Alexion, Mindray, and Sanofi. OAC reports grants or contracts from BMBF, Cidara, EU-DG RTD (101037867), F2G, Gilead, MedPace, MSD, Mundipharma, Octapharma, Pfizer, Scynexis; Consulting fees from Abbvie, AiCuris, Biocon, Cidara, Gilead, IQVIA, Janssen, Matinas, MedPace, Menarini, Moderna, Molecular Partners, MSG-ERC, Noxxon, Octapharma, Pfizer, PSI, Scynexis, Seres; honoraria for lectures from Abbot, Abbvie, Al-Jazeera Pharmaceuticals\/Hikma Gilead, Grupo Biotascana\/United Medical\/Knight ISHAM Working group, MedScape, MedUpdate, Merck\/MSD, Noscendo, Pfizer,Shionogi, StreamedUp; payment for expert testimony from Cidara; Participation on a Data Safety Monitoring Board or Advisory Board from Boston Strategic Partners, Cidara, IQVIA, Janssen, MedPace, Pulmocide, Shionogi, PSI, The Prime Meridian Group; a pending patent currently reviewed at the German Patent and Trade Mark Office; stoke or stoke options from CoRe Consulting and EasyRadiology; other interests from Wiley, outside the submitted work. Outside the submitted work, FGDR reports consulting fess\/honoraria for lectures from MSD, Pfizer, and Gilead Sciences, and travel fees from Pfizer and MSD. JDW reports grants for advisor\/consultant or speaker\/chairman from for MSD, Pfizer, and ThermoFisher (fees and honoraria paid to institution). GD reports honoraria for lectures\/presentations from Gilead, Pfizer, and InfectoPharm. JGM reports personal fees for advisor\/consultant and\/or speaker\/chairman from Gilead and Pfizer. MH received research funding from Gilead Sciences, Astellas, Mundipharma, Euroimmune, MSD, Pulmocide, IMMY, Scynexis, F2G and Pfizer, outside the submitted work. Outside the submitted work, SSK reports fees for lectures\/advisory board from Basilea, MSD, Pfizer, and Hikma. PK reports grants or contracts from German Federal Ministry of Research and Education (BMBF) B-FAST (Bundesweites Forschungsnetz Angewandte Surveillance und Testung) and NAPKON (Nationales Pandemie Kohorten Netz, German National Pandemic Cohort Network) of the Network University Medicine (NUM) and the State of North Rhine-Westphalia; consulting fees Ambu GmbH, Gilead Sciences, Mundipharma Resarch Limited, Noxxon N.V. and Pfizer Pharma; honoraria for lectures from Akademie f\u00fcr Infektionsmedizin e.V., Ambu GmbH, Astellas Pharma, BioRad Laboratories Inc., Datamed GmbH, European Confederation of Medical Mycology, Gilead Sciences, GPR Academy Ruesselsheim, HELIOS Kliniken GmbH, Lahn-Dill-Kliniken GmbH, medupdate GmbH, MedMedia GmbH, MSD Sharp & Dohme GmbH, Pfizer Pharma GmbH, Scilink Comunicaci\u00f3n Cient\u00edfica SC and University Hospital and LMU Munich; participation on an Advisory Board from Ambu GmbH, Gilead Sciences, Mundipharma Resarch Limited and Pfizer Pharma; a pending patent currently reviewed at the German Patent and Trade Mark Office (DE 10 2021 113 007.7); other non-financial interests from Elsevier, Wiley and Taylor & Francis online outside the submitted work. Outside the submitted work, FL reports grants from Pfizer, Gilead, MSD, Novartis, Swiss National Science Foundation, Santos-Suarez Foundation; and honoraria for lectures\/presentation from Gilead, Pfizer, MSD, Mundipharma. Outside the submitted work, CLF reports research grants and\/or personal fees for advisor\/consultant, travel and\/or speaker\/chairman from Gilead, MSD, Pfizer, BioM\u00e9rieux, F2G, IMMY, Shionogi, Astellas Pharma. Outside the submitted work, JM reports research grants and\/or personal fees for advisor\/consultant, and\/or speaker\/chairman from Gilead Sciences, F2G, Shionogi, Mundipharma, Mundipharma, Takeda, and Basilea. Outside the submitted work, IML reports grants from Grifols; consulting fees from MSD, Gilead, Mundipharma, fees for lectures\/advisory board from Gilead, MSD, and Mundipharma; travel support from the European Respiratory Society (Chair Critical Care Group). Outside the submitted work, PM reports fees for lectures\/advisory board from Gilead, MSD, Mundipharma, Pfizer. Outside of the submitted work, GP reports fees for lectures\/advisory board from AstraZeneca, Gilead, Glaxo, Menarini, MSD, Pfizer and SOBI; grants from Adagio Therapeutics, AstraZeneca, Bausch, Fabentech, Pfizer, PharmaMar, Roche, Xenothera. Outside the submitted work, JR reports consulting fees from Pfizer; honoraria for lectures\/presentations from Pfizer, MSD, and Roche; travel support from Roche. Outside the submitted work, J-FT reports grants from Pfizer and MSD; consulting fees from Gilead; honoraria for lectures\/presentations from Mundipharma, Gilead, and Pfizer; Advisor fees from MSD, Pfizer, BD, Aspen, Roche diagnostic, and BioM\u00e9rieux. Outside the submitted work, AT reports consultant\/speaker fees from Pfizer, Poliphor, MSD, Jansen, and OM Pharma. Outside the submitted work, JAV reports consulting fees from F2G and Cidara; honoraria for lectures\/presentations from Melinta. Outside the submitted work, JW reports investigator-initiated research grants, speaker honoraria and travel grants from Pfizer and Gilead. Outside the submitted work, AC reports fees for lectures\/advisory board from Gilead, MSD, Mundipharma, Pfizer. Outside the submitted work, IK reports grants and honoraria for lectures\/presentations from Pfizer and BioM\u00e9rieux. Outside the submitted work, TM reports consultancy fees from Gilead Sciences, Pfizer and AstraZeneca, unrestricted research grants from Gilead Sciences, and travel support from AstraZeneca. Outside the submitted work, KM reports travel support from Gilead. Outside the submitted work, MP reports honoraria for lectures\/presentations from Dia Sorin, MDS, Menarini, Pfizer, and ThermoFisher. Outside the submitted work, LS reports travel support from ESCMID. TC has participated in advisory\/safety monitoring boards or consulted for Cidara, Novartis, MSD Merck Sharp & Dohme AG, Shionogi and Gilead and received grant from European Community (Horizon 2020, HDM-FUN Grant; host-directed medicine in invasive fungal infections, co-applicant) for projects unrelated to the submitted work; all contracts were made with and fees paid to his institution (CHUV).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The present consensus document does not involve patients\u2019 data and does not require approval by Ethical Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent"}}]}}